Live Webinar + Q&A
From Concept to Market: Why Clinical Evaluation must Start at the First Sketch
Tuesday, February 17, 2026
11:00 a.m. Central European Time
Webinar Summary
Why Clinical Evaluation must Start at the First Sketch
Clinical evaluation is often handled at the end of technical documentation development. That approach looks efficient, until the Notified Body questions your endpoints, comparators, benefit-risk logic, or clinical evidence plan and your timeline slips.
In this webinar, we will show how to start clinical evaluation early so it actively guides development decisions. You will learn how an early state-of-the-art assessment helps define what “good enough” looks like clinically, how to avoid the “template trap,” and how to structure clinical evaluation as a living process across the device lifecycle. We will also clarify a common misunderstanding: state-of-the-art supports technology and competitor understanding, but it does not automatically tell you your market access path.
Walk away with a practical approach to planning clinical evaluation to support MDR expectations for sufficient clinical evidence.
What you will Learn
-
How to use clinical evaluation early to set claims, outcomes, and performance thresholds before design is locked
-
What MDR expects from clinical evaluation planning and ongoing updates (not just a one-time report)
-
How to structure an MDR-ready state-of-the-art section, and what it can and cannot tell you
Who Should Attend
RA/QA leaders building or scaling a QMS. Founders, CTOs, and product leads building devices for EU markets. Clinical, medical, and scientific teams responsible for CER, PMCF, and technical documentation.
Webinar Speakers
Núria Gresa
Scientific Affairs Manager
Núria Gresa, PhD, is a Scientific Affairs Manager specializing in Clinical, Quality & Regulatory Affairs for medical devices. Her work focuses on preparing clinical evaluations, PMCF plans and reports, and supports CE‑marking by guiding manufacturers through Notified Body interactions and technical documentation reviews. She has regulatory experience across multiple therapeutic areas and delivers training on MDR, vigilance, and clinical evidence.
Sergi Masgrau
Senior Scientific Affairs Associate
Dr Sergi Masgrau is a biomedical scientist by training with a PhD in Medical Research in cardiovascular physiology and immunology by the Ludwig-Maximilians University of Munich. At Veranex, Sergi provides specialized support on projects related to medical device regulations, including the European Medical Device Regulation (MDR). His responsibilities include reviewing technical documentation for regulatory submissions and contribution to the writing of clinical evaluations and post market documentation. Additionally, he supports clients to comply with authorized representative obligations (EU- and CH-REP, UK RP).
Build smarter programs with an Innovation CRO
When teams are siloed, rework is predictable. Explore the iCRO approach that aligns strategy, evidence generation, and execution across the full device lifecycle.



